Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptid

ATIC Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN936271
-15% Promotion 2026
324,80 €
382,12 €
Sparen Sie 57,32 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 20 bis 26 Werktagen

Kurzübersicht für 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptid (ABIN936271)

Target

ATIC (5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))

Spezies

Säugetier

Quelle

  • 3
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein-Typ

    Synthetic

    Sequenz

    YVVVSTEMQS SESKDTSLET RRQLALKAFT HTAQYDEAIS DYFRKQYSKG

    Produktmerkmale

    A synthetic peptide for use as a blocking control in assays to test for specificity of ATIC antibody,
    Alternative Names: ATIC control peptide, ATIC antibody Blocking Peptide, Anti-ATIC Blocking Peptide, 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/Imp Cyclohydrolase Blocking Peptide, AICAR Blocking Peptide, AICARFT Blocking Peptide, IMPCHASE Blocking Peptide, PURH Blocking Peptide
  • Applikationshinweise

    Optimal conditions should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20 °C long term.
  • Target

    ATIC (5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))

    Hintergrund

    ATIC is a bifunctional protein requiring dimerization for transformylase activity.

    Molekulargewicht

    64 kDa
Sie sind hier:
Chat with us!